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Abstract
Background: Detection of cancer in general practice is challenging because symptoms are diverse. Even so-called
alarm symptoms have low positive predictive values of cancer. Nevertheless, appropriate referral is crucial. As 85%
of cancer patients initiate their cancer diagnostic pathway in general practice, a Continuing Medical Education meeting
(CME-M) in early cancer diagnosis was launched in Denmark in 2012. We aimed to investigate the effect of the CME-M
on the primary care interval, patient contacts with general practice and use of urgent cancer referrals.
Methods: A before-after study was conducted in the Central Denmark Region included 396 general practices, which
were assigned to one of eight geographical clusters. Practices were invited to participate in the CME-M with three-week
intervals between clusters. Based on register data, we calculated urgent referral rates and patient contacts with general
practice before referral. Information about primary care intervals was collected by requesting general practitioners to
complete a one-page form for each urgent referral during an 8-month period around the time of the CME-Ms. CME-M
practices were compared with non-participating reference practices by analysing before-after differences.
Results: Forty percent of all practices participated in the CME-M. There was a statistically significant reduction
in the number of total contacts with general practice from urgently referred patients in the month preceding
the referral and an increase in the proportion of patients who waited 14 days or more in general practice from the
reported date of symptom presentation to the referral date from before to after the CME-M in the CME-M
group compared to the reference group.
Conclusions: We found a reduced number of total patient contacts with general practice within the month
preceding an urgent referral and an increase in the reported primary care intervals of urgently referred patients in the
CME-M group. The trend towards higher urgent referral rates and longer primary care intervals may suggest raised
awareness of unspecific cancer symptoms, which could cause the GP to register an earlier date of first symptom
presentation. The standardised CME-M may contribute to optimising the timing and the use of urgent cancer referral.
Trial registration: NCT02069470 on ClinicalTrials.gov. Retrospectively registered, 1/29/2014
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Background
Danish cancer patients have lower survival and more ad-
vanced disease stages at treatment initiation than many
other European countries [1, 2]. The ability among gen-
eral practitioners (GPs) to interpret and respond to
symptoms plays a pivotal role in cancer detection as 85%
of all cancer patients initiate their diagnostic pathway in
general practice [3, 4]. Increasing evidence suggests that
prompt referral from general practice matters [5–7], and
a UK study found that a high propensity to use urgent
referrals was associated with better survival of cancer
patients [8].
Cancer detection in general practice is, however, a
challenging task. The symptoms of cancer are diverse,
they develop over time, and they tend to mimic symp-
toms of trivial and common conditions [9]. Some symp-
toms are unspecific, e.g. fatigue and weight loss. Others
are considered to be alarm symptoms [10] although they
have a low positive predictive value of cancer of only 2-
10%, depending on age, gender and cancer type [11–13].
Danish cancer patients have increased visits in general
practice already six months before the diagnosis [14],
and one in four waits for more than 20 days in general
practice until referral [4, 15]. Consequently, there may
be room for improvements.
To support the GPs’ decision strategies for referral, a spe-
cific Continuing Medical Education meeting (CME-M) was
developed and implemented as part of the Danish National
Cancer Plan III in 2012 [16]. The developed CME-M con-
sisted of central elements for cancer detection in primary
care [17]. So far, the initial evaluation has shown that the
CME-M has affected the knowledge among GPs on cancer
diagnosis and their attitude towards own role in cancer de-
tection. The CME-M also lowered the GPs’ assessed risk of
cancer in urgently referred patients [18]. Yet, we need to
explore whether the change in GPs’ knowledge and attitude
was translated into a behavioural change.
The aim of this study was to investigate the effect of
the CME-M on the use of urgent cancer referrals by
investigating urgent referral rates and the timing of
urgent referrals in terms of length of primary care
interval and number of patient contacts with general
practice before referral.
Methods
The setting of the study was the Central Denmark Region
with approx. 1.3 million inhabitants and 8,000 new cancer
patients annually [19]. The Danish healthcare system is
tax-funded with free access for citizens to medical advice
and treatment in general practice and hospitals. More
than 98% of the Danish citizens are listed with a specific
general practice, which they must consult for medical ad-
vice. GPs serve as gatekeepers to specialised care, such as
diagnostic investigations and hospital care [20]. In order
to ensure consistency in the GPs’ selection of patients for
urgent cancer referrals, national referral guidelines were
made for each cancer fast-track pathway [21, 22]. As an
example, the referral guideline for colorectal cancer state
that cancer should be considered if a patient above
40 years of age presents at least one of the following
symptoms: visible rectal bleeding, discharge of mucus or
changes in bowel habits or stools for a four-week period,
iron-deficiency anaemia and unspecific symptoms as pain
or weight loss [21]. All Danish citizens have a civil per-
sonal registration (CPR) number, which enables linkage of
information at the individual level between national regis-
tries and allows identification of the practice at which each
citizen is listed [23].
Design
We conducted a before-after study with a stepwise en-
rolment of GPs in the CME-Ms [17]. All practices in the
Central Denmark Region were allocated to one of eight
clusters by exploiting the already existing municipal
units. The Regional Cancer Quality Unit assigned the
random order in which all GPs (practices) in the cluster
were offered the CME-M at 3-week intervals within the
period 1 September 2012 to 1 May 2013 (Fig. 1). GPs
were registered if they participated in the CME-M [17].
Intervention: continuing medical education meeting
The content of the CME-M was developed through a
comprehensive process, which has been described previ-
ously in detail [17]. The CME-M provided the GPs with
new knowledge on symptoms of cancer and presented
risk assessment tools (RATs) for lung, colorectal, ovarian
and prostate cancer [13, 24]. Use of investigations and
reasons for missed opportunity [25, 26] were discussed
in terms of risk of false reassurance [27, 28]. Mecha-
nisms affecting referral thresholds were debated based
on patient cases [29].
Outcomes
Use of urgent referrals was operationalised as: 1) urgent re-
ferral rate per GP (i.e. number of urgently referred patients
during six months per GP in the practice) and 2) urgent re-
ferral rate per 1000 patients in the practice (i.e. number of
urgently referred patients during six months per 1000 listed
patients aged ≥ 40 years in the practice). Timing of urgent
referrals was operationalised as: 1) prior contacts (i.e. num-
ber of daytime contacts with general practice from urgently
referred patients before referral) and 2) primary care
interval (i.e. number of days from first presentation in gen-
eral practice until urgent referral to secondary care) [30].
Practice population
The practices were identified in the Danish provider
number registry. The number of included practices
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depended on the outcome to be measured. For urgent
referral rates, practices were included if registered from
six months before to six months after their CME-M
date. For prior contacts, practices were included if regis-
tered from 18 months before to six months after their
CME-M date. For primary care interval, practices were
included if registered in the period from 1 September
2012 to 1 May 2013 provided that they had completed
one-page forms (Additional file 1).
Patient populations
The urgently referred patients were identified by apply-
ing an algorithm, which was developed for the purpose,
to the primary care referral database [31]. The algorithm
had a sensitivity of 93.6%, a specificity of 97.3%, a posi-
tive predictive value of 83.6% and a negative predictive
value of 99.0% for identifying urgently referred patients
aged ≥ 40 years without prior cancer among all referred
patients aged ≥ 40 years [31].
For urgent referral rates, patients were included if: 1)
identified by the algorithm, 2) referred from an included
practice from six months before until six months after
the CME-M date of the practice, 3) age ≥ 40 years and 4)
no prior cancer.
For prior contacts, patients were included on the same
criteria as above. Furthermore, they were also required
to have been listed with the same practice for one year
prior to the referral date.
For primary care interval, patients were included if: 1)
identified by the algorithm, 2) referred from an included
practice from 1 September 2012 to 1 May 2013, 3) age ≥
40 years, 4) no prior cancer and 5) receipt of one-page
form stating the date of first symptom presentation and
the date of referral.
Patients already diagnosed with cancer were excluded
based on data in the Danish Cancer Registry [32] regis-
tered in accordance with the International Classification of
Diseases, 10th revision: C0-C9, except for non-melanoma
skin cancer (C44) [33].
Variables
Patient contacts with general practice were obtained
from the Danish National Health Service Register [34].
The registration is based on fee-for-service remuneration
of the providing GP, and the records in this registry are
generally considered highly complete [35]. We used two
variables: 1) face-to-face (F2F) contacts and 2) total con-
tacts, which included F2F, phone and e-mail contacts.
Date of first presentation of symptom in general prac-
tice and date of referral were collected by requesting
GPs to complete a one-page form including the patient’s
CPR number each time a patient was referred for sus-
pected cancer during an 8-month period around the
CME-Ms (1 September 2012 to 1 May 2013) (Fig. 1)
[17]. Furthermore, in the hospital patient administrative
system, patients registered as investigated as part of an
Fig. 1 Time periods used for classifying patient populations. The cluster-specific time period used for identifying urgently referred patients in the
primary care referral database (light boxes= time before CME-M; dark boxes = time after CME-M). The method at the top was applied for evaluating
CME-M effect on referral rates and patient contacts with general practice. The method at the bottom was used for evaluating CME-M effect on primary
care intervals
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urgent referral were identified every other week. If the
one-page form was missing, the relevant GP was re-
quested to complete a form and to specify the patient’s
route to investigation. This was done to increase the
completeness of data for urgently referred patients.
The development, pilot-testing, coding and data trans-
fer of the forms have been reported elsewhere [17].
Age and gender distribution of the patient population
for each practice was obtained from the patient list sys-
tem on 1 January 2013.
The Danish Deprivation Index (DADI), which is used
to adjust for differences in socioeconomic factors, was
calculated based on data from the Integrated Database
for Labour Market Research [36]. The DADI has a value
between 10 and 100; the higher the number, the more
deprived population. The variables used were: (i) propor-
tion of adults aged 20–59 years with no employment, (ii)
proportion of adults aged 25–59 years with no profes-
sional education, (iii) proportion of adults aged 25–59
years with low income, (iv) proportion of adults aged
18–59 years receiving public welfare benefits (transfer
payments or social security benefits), (v) proportion of
children from parents with no education and no profes-
sional skills, (vi) proportion of immigrants, (vii) propor-
tion of adults aged 30+ years living alone and (viii)
proportion of adults aged 70+ years with low income
(= the lowest national quartile).
A modified Charlson Comorbidity Index score [37] was
obtained for each referred patient by using data from the
Danish National Patient Register with the referral date as
the index date [38]. We divided the comorbidity scores
into “none” (no recorded disease), “moderate” (score of 1
or 2) and “high” (score of 3 or more) [15].
The suspected cancer type stated at the one-page form
was divided into two groups of cancer detection diffi-
culty based on the available evidence [39]. Cancers con-
sidered easier to detect included suspected cancer in
kidney, bladder, breast, head and neck, female genitalia,
nevus (melanoma), penis, testis and gastrointestinal sys-
tem, whereas cancers considered harder to detect included
suspected cancer in pancreas, liver and gall bladder, brain,
lymph node and bone marrow, lung, prostate, connective
tissue including fat, muscle and bones, and suspicion
based on unspecific serious symptoms.
Statistical analyses
Practices were divided into two groups: practices with at
least one CME-M-participating GP (“CME-M practices”)
and practices without any CME-M-participating GPs
(“reference practices”).
The time point for a CME-M session for each cluster
was defined as the point that separated the time of obser-
vation in “before CME-M” and “after CME-M” (Fig. 1).
The data collected before and after the CME-M provided
paired responses for each outcome. The practice and pa-
tient populations were described by their characteristics.
Urgent referral rates were indirectly age-sex standar-
dised as we used the full patient population in the Central
Denmark Region as standard population divided into ten-
year age groups (40–49, 50–59, etc.).
The CME-M effect on urgent referral rates was ana-
lysed using mixed-effects negative binomial regression
[40] with a random effect associated with the intercept
for each practice to make comparisons before and after
CME-M within and between groups. The model allowed
dealing with repeated observations on practice level. The
time of observation (before and after CME-M) was treated
as a fixed-effect variable. In the analysis of urgent referral
rates per GP, the number of GPs per practice was treated
as an exposure variable. The effects within groups were
reported as incidence rate ratios (IRRs). Comparison of ef-
fects between groups was reported as a ratio of the IRRs.
The analyses were adjusted for cluster, type of practice
(single-handed/partnership) and DADI index. A single-
handed practice was defined as a practice with only one
GP. A stratified analysis was performed on practice type.
Prior contacts were measured in different time inter-
vals: 0–1 month, 0–3 months and 4–6 months preced-
ing referral. The number of contacts during the 7–12
months preceding referral was calculated to estimate an
average habitual contact rate per month for each patient.
The CME-M effect on prior contacts was analysed
using mixed-effects negative binomial regression with a
random effect associated with the intercept for each
practice and time of observation as a fixed-effect variable
to make comparisons before and after CME-M within
and between groups while adjusting for patient cluster-
ing in the practices. The results were reported as IRRs
or a ratio of the IRRs. Due to convergence problems for
F2F within the last month preceding the referral, the
analysis was based on ordinary negative binomial regres-
sion applying cluster robust variance at practice level.
For the 10% of patients with most frequent contact,
the number of F2F contacts and total contacts were
dichotomised based on the 90th percentile (number of
contacts within 0–1 month was 4 for F2F and 5 for total
contacts). A mixed-effects logistic regression [41]
allowed for random effects at practice level, and the ob-
servation time (before and after) was treated as a fixed-
effect variable. The effects were reported as odds ratios
(ORs) for having most contacts within groups and ratio
of the ORs between groups.
The analyses were adjusted for cluster, practice type,
patient gender, age, habitual monthly contact rate and
comorbidity. Furthermore, a stratified analysis on prac-
tice type was performed.
The primary care intervals were calculated as me-
dians, 75th and 90th percentiles. We dichotomised the
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intervals based on the 75th and 90th percentiles from be-
fore the CME-M. Comparisons within and between
groups were estimated with mixed-effects logistic regres-
sion with a random effect associated with the intercept for
each practice adjusting for patient clustering in the prac-
tices. The results were reported as ORs or a ratio of the
ORs. The analyses were adjusted for cluster, practice type,
patient gender, age, co-morbidity and cancer detection dif-
ficulty. Furthermore, stratified analyses were performed
on cancer detection difficulty and type of practice.
The statistical software Stata 13.0 (StataCorp LP, TX,
USA) was used for the analyses [42].
Results
Study population
A total of 148 of the 396 general practices (37.4%) par-
ticipated in the CME-M (Table 1). Compared to the ref-
erence practices, the CME-M practices were more often
partnership practices, the GPs were slightly younger and
more often female, the practice population size per GP
was lower, the practice population consisted of fewer
male and slightly less deprived patients (Tables 1 and 2).
The patients used for calculation of the primary care
interval were included by 139 CME-M practices and 199
reference practices (Table 3).
Impact of CME-M on urgent referral rates
The CME-M was associated with a two-fold relative rise
in urgent referral rates per GP when comparing CME-M
practices with reference practices. Within the CME-M
group, this increase was statistically significant (IRR:
1.05 (95% CI: 1.01;1.08) (Table 4). Each CME-M practice
referred one patient more per 1000 patients in their
underlying practice population during the 6-month
period after the CME-M compared to before; this in-
crease was three times higher than the increase in
Table 1 Characteristics of practices, GPs and patients used for CME-M impact on urgent referral rates
Reference group CME-M group
Study base, Practices, N 248 148
Proportion of solo practices (95% CI) 0.60 (0.54;0.66) 0.30 (0.23;0.38)
GPs per practice, mean (range) 1.72 (1–5) 2.60 (1–10)
GPs, N 425 385
Proportion of males (95% CI) 0.59 (0.54;0.64) 0.48 (0.43;0.53)
Mean age (95% CI) 52.6 (51.7;53.4) 51.6 (50.8;52.4)
Underlying practice populations, N 661,805 570,926
Mean list size, patients≥ 40 yrs. per practice 1353 1920
Mean list size, patients≥ 40 yrs. per GP in practice 787 738
Proportion of male patients aged≥ 40 yrs. (95% CI) 0.50 (0.49;0.50) 0.48 (0.47;0.49)
Age groups (yrs.), proportion of all patients ((%)(95% CI))
0–39 48.6 (47.4; 49.9) 49.9 (48.4; 51.3)
40–49 14.1 (13.8;14.4) 14.0 (13.7;14.4)
50–59 13.4 (13.0;13.7) 12.7 (12.2;13.1)
60–69 12.5 (12.0;12.9) 12.1 (11.6;12.6)
70–79 7.3 (6.9;7.6) 7.2 (6.8;7.6)
80–90 3.5 (3.3; 3.7) 3.4 (3.2; 3.6)
Above 90 0.76 (0.7; 0.8) 0.73 (0.7; 0.8)
Mean DADI index (95% CI) 26.9 (25.9;27.8) 25.5 (24.4;26.5)






Proportion of males (95% CI) 0.47 (0.45;0.48) 0.45 (0.44;0.46) 0.44 (0.43;0.46) 0.44 (0.43;0.45)
Mean age (95% CI) 63.0 (62.7;63.3) 63.1 (62.9;63.4) 62.6 (62.3;62.9) 62.8 (62.5;63.1)
Comorbiditya (%)
None 75.5 74.8 76.2 75.2
Medium 20.9 21.3 19.9 21.0
High 3.6 3.9 3.9 3.8
Abbreviations: CME-M continuing medical education meeting, GP general practitioner, CI confidence interval; yrs., years, DADI Danish Deprivation Index
aComorbidity scores were divided into “none” (no recorded disease),“ moderate” (score of 1 or 2) and “high” (score of 3 or more)
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reference practices (Table 4). When we stratified on
practice type, the partnership practices who participated
in the CME-M increased their urgent referral rate per
GP (IRR: 1.06 (95% CI: 1.02;1.10) and their urgent refer-
ral rate per 1000 patients (IRR: 1.06 (95% CI: 1.01;1.12)
from before to after the CME-M.
Compared with the reference practices, none of these
findings were statistically significant (Table 4). Note that
the stratified analyses on practice type showed a higher
use of urgent referrals among CME-M-participating
single-handed practices compared to non-participating
single-handed practices (Table 4).
Impact of CME-M on prior contacts
There was a statistically significant reduction in the
number of total contacts within the last month before
referral in the CME-M group compared to the reference
group (IRR-ratio: 0.97 (95% CI: 0.94;0.99)) (Table 5).
Note the tendency that the proportion of patients con-
tacting the most in terms of total contacts decreased
from before to after in the CME-M group (OR-ratio:
0.90 (95% CI: 0.86;1.02)) (Table 5).
Impact of CME-M on primary care intervals
The proportion of patients who waited 14 days or more
in the CME-M practices statistically significantly in-
creased from before to after the CME-M compared to
the reference practices (OR-ratio: 1.47 (95% CI:
1.06;2.03)) (Table 6). This was also seen as a tendency
for other estimates although these figures were not sta-
tistically significant. When we stratified on cancer
detection difficulty, no statistically significant differences
were found in the primary care intervals (Table 6).
Sensitivity analyses
When we excluded patients urgently referred within one
or two months after the CME-M date, the CME-M effect
on urgent referral rates and prior contacts did not differ
considerably from the main results (Additional file 2).
Discussion
Main findings
Forty percent of general practices participated in the
cancer diagnostic CME-M. Increased use of urgent refer-
rals was found in the CME-M group from before to after
the CME-M. However, this increase was only small in
absolute numbers and was not statistically significantly
different from the figures for the reference group. Com-
pared with the reference group, the CME-M seemed to
reduce the number of total contacts with general prac-
tice in the CME-M group during the last month before
the urgent referral. Furthermore, the proportion of pa-
tients with more than five contacts in total during the
last month decreased in the CME-M group; together this
indicates a lower referral threshold.
The CME-M was associated with an increase in the re-
ported primary care intervals.
Strength and limitations
The before-after design allowed us to perform a robust
evaluation with corrections for baseline measures of a
natural experiment. We controlled for calendar time by
Table 2 Characteristics of practices, GPs and patients used for CME-M impact on patients’ prior contacts
Reference group CME-M group
Practices, N 240 144
Proportion of solo practices (95% CI) 0.60 (0.54;0.66) 0.29 (0.22;0.37)
GPs per practice, mean (range) 1.73 (1–5) 2.63 (1–10)
GPs, N 415 377
Proportion of males (95% CI) 0.60 (0.55;0.64) 0.48 (0.43;0.53)
Mean age (95% CI) 52.9 (52.0;53.7) 51.7 (50.9;52.5)
Referred patients (age≥ 40 yrs.), N Before CME-M, N = 7,659 After CME-M, N = 7,731 Before CME-M, N = 7,121 After CME-M, N = 7,417
Proportion of males (95% CI) 0.46 (0.45;0.47) 0.46 (0.45;0.47) 0.44 (0.43;0.46) 0.44 (0.43;0.45)
Mean age (95% CI) 63.1 (62.8;63.4) 63.2 (62.9;63.5) 62.7 (62.4;63.0) 62.9 (62.6;63.2)
Comorbidity (%)a
None 75.9 75.3 76.4 75.7
Medium 20.7 21.1 19.8 20.8
High 3.4 3.6 3.8 3.6
Mean habitual F2F monthly contact rateb (95% CI) 0.60 (0.58;0.61) 0.57 (0.56;0.59) 0.61 (0.59;0.62) 0.60 (0.58;0.61)
Mean habitual total monthly contact rateb (95% CI) 1.05 (1.03;1.08) 1.02 (1.00;1.05) 1.07 (1.05;1.10) 1.04 (1.01;1.06)
Abbreviations: CME-M continuing medical education meeting, GP general practitioner, CI confidence interval; yrs., years, DADI Danish Deprivation Index, F2F face-to-face
aComorbidity scores were divided into “none” (no recorded disease), “ moderate” (score of 1 or 2) and “high” (score of 3 or more)
bMean habitual monthly contact rate: average contacts per month based on number of contacts 7–12 months preceding referral for each patient
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comparing CME-M group and reference group and by
including the stepwise enrolment of GPs in the CME-M
into the modelling of data, which diminished the influ-
ence of increasing cancer-related knowledge over time.
Another strength was the well-defined and well-
described study population and the valid identification
of the individuals listed with the studied practices. Add-
itionally, we were able to link selected information on all
included individuals to relevant register data at the indi-
vidual level.
The main limitation of this study was the natural se-
lection to participate in the CME-M. Participating prac-
tices and GPs differed from non-participating practices
and GPs, particularly single-handed practices differed on
the use of urgent referrals (Table 4). This indicates that
CME-M participating practices cannot be directly
compared to non-participating practices. The CME-M
practices had a higher use of urgent referrals among
1000 patients at baseline; this indicates that their poten-
tial for improvement was lower than for the entire study
base, which may have underestimated the effect of the
CME-M. However, the true direction of such bias is dif-
ficult to establish.
The use of the referral algorithm allowed us to base
the identification of urgently referred patients on register
data [31]. We have no reason to believe that patients
from CME-M practices had different chances of being
identified by the algorithm than patients from reference
practices. On the contrary, the patient population used
for the evaluation of the CME-M effect on the primary
care interval required that the referring GP completed
the one-page form about the urgently referred patient.
The CME-M practices were more likely to complete one-
page forms (Table 2), whereas the reference practices lost
Table 3 Characteristics of practices, GPs and patients used for CME-M impact on patients’ primary care interval
Reference group CME-M group
Practices, N (proportion of study base %) 199 (82.9%) 139 (93.9%)
Proportion of solo practices (95% CI) 0.53 (0.46;0.60) 0.26 (0.19;0.35)
GPs per practice, mean (range) 1.85 (1–5) 2.66 (1–10)
GPs, N 369 370
Proportion of males (95% CI) 0.57 (0.52;0.62) 0.47 (0.42;0.53)
Mean age (95% CI) 52.1 (51.2;53.0) 51.4 (50.6;52.2)








Proportion of males (95% CI) 0.46 (0.45;0.47) 0.45 (0.44;0.47) 0.44 (0.43;0.46) 0.44 (0.43;0.46)
Mean age (95% CI) 62.8 (62.5;63.1) 63.0 (62.6;63.4) 62.5 (62.1;62.8) 62.8 (62.5;63.2)
Comorbidity (%)
None 75.3 74.7 75.8 74.8
Medium 20.7 21.3 19.9 21.2
High 4.0 4.0 4.3 3.9
Referred patients with known primary care intervals













Proportion of males (95% CI) 0.52 (0.49;0.55) 0.54 (0.50;0.57) 0.48 (0.45;0.51) 0.47 (0.44;0.50)
Mean age (95% CI) 64.9 (64.2;65.6) 64.5 (63.6;65.3) 64.5 (63.8;65.3) 64.8 (64.1;65.5)
Comorbiditya (%)
None 76.7 75.4 76.1 75.6
Medium 19.7 20.2 20.1 21.0
High 3.6 4.4 3.8 3.4
Cancer detection difficultyb (%)
Easier to detect 72.2 68.4 69.2 70.2
Harder to detect 23.1 25.4 26.4 24.9
Missing information 4.6 6.2 4.4 4.9
Abbreviations: CME-M continuing medical education meeting, GP general practitioner, CI confidence interval; yrs., years
aComorbidity scores were divided into “none” (no recorded disease), “ moderate” (score of 1 or 2) and “high” (score of 3 or more)
bThe suspected cancer was divided based on cancer detection difficulty: 1) easier to detect included kidney, bladder, breast, head and neck, female genitalia,
nevus (melanoma), penis, testis and gastrointestinal and 2) harder to detect included unspecific symptoms, pancreas, liver and gall bladder, brain, lymph node
and bone marrow, lung, prostate and connective tissue, including fat, muscle and bones
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compliance over time. We do not know whether this was
a differentiated non-response (e.g. in cases with long pri-
mary care intervals), but it could be the case as also indi-
cated by the paradoxical result. However, the proportion
of patients in the “harder to detect” group of referrals ac-
tually increased in the reference group after the CME-M
[39].
To investigate the reasons for the observed increase in
the primary care interval combined with an indication of
lowered referral threshold, we performed sensitivity ana-
lyses. These did not point towards a delayed effect of the
CME-M or a “cleaning up process” of patients who had
recently been seen in general practice because of unspe-
cific symptoms. The most likely explanation of our find-
ing is a change in the awareness of unspecific symptoms
among GPs in CME-M practices, which could have led
the GPs to report an earlier date of first symptom pres-
entation. Thus, the GPs may have gained a more realistic
idea about the usual time intervals in general practice
for patients suspected of cancer.
Comparison with other studies and clinical implications
To our knowledge, this study is among the first to evalu-
ate a CME-M on GPs’ use and timing of urgent cancer
referrals. In accordance with our findings, an English be-
fore-after study found that the use of RATs for lung and
colorectal cancer in general practice was associated with
an increased number of urgent referrals during a 6-month
period [43]. The reason for this could be that the GPs’
awareness of potential cancer symptoms and attitude to-
wards urgent cancer referral changed through the CME-
M. Similar results have also been found in qualitative
studies about the use of RATs [44, 45] and in our previous
analysis of the impact of the CME-M on GP knowledge,
attitude and intentions [18].
Our intervention was developed on the basis of theor-
etical frameworks and reviews of empirical results to en-
sure optimal likelihood of positive effect [44–47]. The
CME-M consisted of a variety of elements [18], and we
could not validly identify the most effective parts of the
CME-M; this calls for further research in changing the
GPs’ behaviour [46].
In our study, the non-participating practices were
more often single-handed, the GPs were more often
males, and their practice population was larger, more de-
prived and with more male patients than in participating
practices. Similar findings were also reported in a com-
prehensive quality development project on chronic dis-
eases conducted in the Central Denmark Region in 2010
[47]. These findings may result from differences in the
GPs’ possibility to participate (e.g. time constraints) [48].
However, it may also be explained by the theories of
varying readiness for change of behaviour [49]; some
GPs belong to a group known to be susceptible for new
knowledge (innovators, early adopters and early major-
ity), whereas other GPs are known to be sceptical (late
majority and laggards). One way to change the pattern
of non-participation could perhaps be to develop specific
CME initiatives to better fit the GPs’ preferences for
education and individual learning style [50].
Conclusion
We found a statistically significant reduction in the
number of total contacts with general practice within
the month preceding an urgent referral and an increase
in the reported primary care intervals from before to
after in the CME-M group compared to the reference
group. A CME-M may contribute to changing the
threshold for referring the patients and the GPs’ under-
standing of the primary care interval.
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